Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06934473

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The present study investigates the postprandial role of endogenous glucose-dependent insulinotropic polypeptide (GIP) on cardiovascular haemodynamics, hormone responses, and hypotensive symptoms during a tilt test.

Detailed description

The study is an exploratory, randomised, placebo-controlled, double-blinded crossover study comprising four experimental days. Each experimental day consists of a mixed meal test or drinking water, a double-blinded continuous infusion of GIP(3-30)NH2 or placebo or GIP(1-42) or placebo, and three tilt tests. Sixteen healthy men and women will be included in the study.

Conditions

Interventions

TypeNameDescription
OTHERGIP(3-30)NH2 / study toolSelective antagonist of the GIPR, GIP(3-30)NH2
OTHERSaline (NaCl 0,9 %) (placebo)Placebo (NaCl 0,9%)
OTHERGIP(1-42)Agonist of the GIPR, GIP(1-42)

Timeline

Start date
2025-05-21
Primary completion
2026-01-31
Completion
2026-01-31
First posted
2025-04-18
Last updated
2025-09-08

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06934473. Inclusion in this directory is not an endorsement.